跳至主要内容
临床试验/NCT05022368
NCT05022368Enrolling By Invitation1 期

Surgical Safety Device Use During Transoral Surgery

Nationwide Children's Hospital2 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2021年5月24日最近更新:
适应症

试验速览

阶段
1 期
状态
Enrolling By Invitation
入组人数
250
试验地点
2
主要终点
Surgical Field Visibility

研究概览

简要总结

The investigators are studying the use of a new medical device developed at Nationwide Children's. This technology has been licensed and produced by Zotarix LLC, a medical device company. It is designed to aid in retraction and provide protection of the lips during surgery. The investigators are not recording any of your identifiable personal health information except for the surgery date. This device, called the LabraGuard is a sterile, soft medical grade silicone, and no alternative device with these exact protective properties exists, and the investigators are trying to learn more about how it performs in different age children.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
— 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects 21 years of age and under
  • Having a surgical procedure done through the mouth where the lips are at risk of injury
  • Performed by attendings from either the Otolaryngology department or the Dental department.
  • Subject/Subject's guardian provides consent to be in the study

排除标准

  • Allergy to silicone
  • Unable to achieve good fit

结局指标

主要结局

Surgical Field Visibility

时间窗: baseline

Surgeons level of visibility of the oropharynx on a scale of 1 to 10

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tendy Chiang

Assistant professor

Nationwide Children's Hospital

研究点 (2)

Loading locations...

相似试验